Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
33,37 USD | +0,06% | -1,77% | +31,07% |
Attività
Numero di dipendenti: 187
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Small Molecule Therapeutics
100,0
%
| 47 | 100,0 % | 79 | 100,0 % | +67,84% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 47 | 100,0 % | 79 | 100,0 % | +67,84% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Nello Mainolfi
FOU | Founder | 45 | 01/09/15 |
Bruce Jacobs
DFI | Director of Finance/CFO | 54 | 15/07/19 |
Juliet Williams
CTO | Chief Tech/Sci/R&D Officer | - | 05/05/21 |
Kevin Dushney
CTO | Chief Tech/Sci/R&D Officer | - | 03/02/21 |
Jared Gollob
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/09/18 |
Vijay Sabesan
CTO | Chief Tech/Sci/R&D Officer | 51 | 06/12/21 |
Jeremy Chadwick
COO | Chief Operating Officer | 61 | 22/05/23 |
Investor Relations Contact | - | 01/07/23 | |
Aimee Mishkin
LAW | General Counsel | - | 01/04/20 |
Melissa Brody
PRN | Corporate Officer/Principal | - | 02/11/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 28/03 |
Joanna Horobin
BRD | Director/Board Member | 69 | 01/05/18 |
John Maraganore
BRD | Director/Board Member | 60 | 17/01/22 |
Elena Ridloff
BRD | Director/Board Member | 44 | 12/03/21 |
Bruce Booth
FOU | Founder | 49 | 01/04/16 |
Pamela Esposito
BRD | Director/Board Member | 50 | 04/09/20 |
Jeffrey Albers
BRD | Director/Board Member | 52 | 01/07/20 |
Leigh Morgan
BRD | Director/Board Member | - | 08/07/22 |
Victor Sandor
BRD | Director/Board Member | 57 | 03/11/22 |
Nello Mainolfi
FOU | Founder | 45 | 01/09/15 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 61 111 678 | 60 515 185 ( 99,02 %) | 0 | 99,02 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+31,07% | 2,05 Mrd | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione KYMR
- Società Kymera Therapeutics, Inc.